These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29568102)

  • 1. Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity.
    Liu L; Wang Y; Wang J; Dong Y; Chang S; Liu X; Lutfy K; Chen H; Friedman TC; Jiang M; Liu Y
    Int J Obes (Lond); 2018 Dec; 42(12):1999-2011. PubMed ID: 29568102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
    Yan C; Yang H; Wang Y; Dong Y; Yu F; Wu Y; Wang W; Adaku U; Lutfy K; Friedman TC; Tian S; Liu Y
    Int J Obes (Lond); 2016 Aug; 40(8):1233-41. PubMed ID: 27102048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.
    Wang J; Wang Y; Liu L; Lutfy K; Friedman TC; Liu Y; Jiang M; Liu Y
    Clin Sci (Lond); 2019 Nov; 133(21):2189-2202. PubMed ID: 31696216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.
    Wang Y; Liu L; Du H; Nagaoka Y; Fan W; Lutfy K; Friedman TC; Jiang M; Liu Y
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E543-51. PubMed ID: 24381005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue.
    Bujalska IJ; Hewitt KN; Hauton D; Lavery GG; Tomlinson JW; Walker EA; Stewart PM
    Endocrinology; 2008 May; 149(5):2584-91. PubMed ID: 18218694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.
    Wang Y; Nakagawa Y; Liu L; Wang W; Ren X; Anghel A; Lutfy K; Friedman TC; Liu Y
    Diabetologia; 2011 Feb; 54(2):440-50. PubMed ID: 21052977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration.
    Do TTH; Marie G; Héloïse D; Guillaume D; Marthe M; Bruno F; Marion B
    J Steroid Biochem Mol Biol; 2019 Jan; 185():150-162. PubMed ID: 30145227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.
    Wamil M; Battle JH; Turban S; Kipari T; Seguret D; de Sousa Peixoto R; Nelson YB; Nowakowska D; Ferenbach D; Ramage L; Chapman KE; Hughes J; Dunbar DR; Seckl JR; Morton NM
    Diabetes; 2011 Apr; 60(4):1158-67. PubMed ID: 21350084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
    Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
    Liu Y; Nakagawa Y; Wang Y; Liu L; Du H; Wang W; Ren X; Lutfy K; Friedman TC
    J Mol Endocrinol; 2008 Aug; 41(2):53-64. PubMed ID: 18524870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
    Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue.
    Bursać BN; Djordjevic AD; Vasiljević AD; Milutinović DD; Veličković NA; Nestorović NM; Matić GM
    J Nutr Biochem; 2013 Jun; 24(6):1166-72. PubMed ID: 23253598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle.
    Zielinska AE; Fletcher RS; Sherlock M; Doig CL; Lavery GG
    Cell Biochem Funct; 2017 Jul; 35(5):269-277. PubMed ID: 28749080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.
    Semjonous NM; Sherlock M; Jeyasuria P; Parker KL; Walker EA; Stewart PM; Lavery GG
    Endocrinology; 2011 Jan; 152(1):93-102. PubMed ID: 21106871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.
    Lee MJ; Pramyothin P; Karastergiou K; Fried SK
    Biochim Biophys Acta; 2014 Mar; 1842(3):473-81. PubMed ID: 23735216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte-Specific Enhancement of Angiotensin II Type 1 Receptor-Associated Protein Ameliorates Diet-Induced Visceral Obesity and Insulin Resistance.
    Azushima K; Ohki K; Wakui H; Uneda K; Haku S; Kobayashi R; Haruhara K; Kinguchi S; Matsuda M; Maeda A; Toya Y; Yamashita A; Umemura S; Tamura K
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28264860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
    Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
    J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
    De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
    Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.